CoChat

Pathogenesis of Brain Edema and Investigation into Anti-Edema Drugs

Open access
Michinaga, Shotaro, Koyama, Yutaka · 2015 · International Journal of Molecular Sciences

The DOI matches its Crossref record; 197 of the 202 references it cites were found in a registry or an index.

Abstract

Brain edema is a potentially fatal pathological state that occurs after brain injuries such as stroke and head trauma. In the edematous brain, excess accumulation of extracellular fluid results in elevation of intracranial pressure, leading to impaired nerve function. Despite the seriousness of brain edema, only symptomatic treatments to remove edema fluid are currently available. Thus, the development of novel anti-edema drugs is required. The pathogenesis of brain edema is classified as vasogenic or cytotoxic edema. Vasogenic edema is defined as extracellular accumulation of fluid resulting from disruption of the blood-brain barrier (BBB) and extravasations of serum proteins, while cytotoxic edema is characterized by cell swelling caused by intracellular accumulation of fluid. Various experimental animal models are often used to investigate mechanisms underlying brain edema. Many soluble factors and functional molecules have been confirmed to induce BBB disruption or cell swelling and drugs targeted to these factors are expected to have anti-edema effects. In this review, we discuss the mechanisms and involvement of factors that induce brain edema formation, and the possibility of anti-edema drugs targeting them.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms16059949

Cites

197 of 197 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Pathology of vasogenic and cytotoxic edema. Vasogenic edema: After brain injuries, endothelial tight junctions are disrupted by inflammatory reactions and oxidative stress. Moreover, activated glial cells release vascular permeability factors and inflammatory factors, and these factors accelerate blood-brain barrier (BBB) hyperpermeability. These events cause extravasation of fluid and albumin, leading to extracellular accumulation of fluid into the cerebral parenchyma. Cytotoxic edema: Brain insults induce intracellular ATP depletion, resulting in mitochondrial dysfunction and oxidative stress. These events cause a disturbance of intra-extracellular ion balance. As a result, excessive inflows of extracellular fluid and Na+ into cells are induced, leading to cell swelling. Because the extracellular Na+ contents are decreased by excessive inflow into cells, the outflow of Na+ and fluid from blood vessels is compensatorily accelerated. The intravascular Na+ outflow results in extracellular fluid accumulation in the cerebral parenchyma. Blue arrows: flow of water, green arrows: flow of Na+, orange spheres: albumin, green spheres: Na+, blue columns: water channel, green columns: ion transporter and red columns: ion channel.
Figure 1 Pathology of vasogenic and cytotoxic edema. Vasogenic edema: After brain injuries, endothelial tight junctions are disrupted by inflammatory reactions and oxidative stress. Moreover, activated glial cells release vascular permeability factors and inflammatory factors, and these factors accelerate blood-brain barrier (BBB) hyperpermeability. These events cause extravasation of fluid and albumin, leading to extracellular accumulation of fluid into the cerebral parenchyma. Cytotoxic edema: Brain insults induce intracellular ATP depletion, resulting in mitochondrial dysfunction and oxidative stress. These events cause a disturbance of intra-extracellular ion balance. As a result, excessive inflows of extracellular fluid and Na+ into cells are induced, leading to cell swelling. Because the extracellular Na+ contents are decreased by excessive inflow into cells, the outflow of Na+ and fluid from blood vessels is compensatorily accelerated. The intravascular Na+ outflow results in extracellular fluid accumulation in the cerebral parenchyma. Blue arrows: flow of water, green arrows: flow of Na+, orange spheres: albumin, green spheres: Na+, blue columns: water channel, green columns: ion transporter and red columns: ion channel.CC BY · PubMed Central
Figure 2 Brain edema model in experimental animals. (A) Cold injury is performed by inflicting freeze stimulation on the hemisphere of the skull of the animal (A1). After cold injury, BBB disruption is indicated by evaluating extravasation of Evans blue dye (A2); (B) Fluid percussion injury is performed by an injury to the intact dura after craniectomy by impacts of rapidly pushed fluid (B1,B2). As well as cold injury, the extravasation of Evans blue dye is observed (B3).
Figure 2 Brain edema model in experimental animals. (A) Cold injury is performed by inflicting freeze stimulation on the hemisphere of the skull of the animal (A1). After cold injury, BBB disruption is indicated by evaluating extravasation of Evans blue dye (A2); (B) Fluid percussion injury is performed by an injury to the intact dura after craniectomy by impacts of rapidly pushed fluid (B1,B2). As well as cold injury, the extravasation of Evans blue dye is observed (B3).CC BY · PubMed Central
Figure 3 Involvement of key molecules and effects of candidate anti-edema drugs in brain edema. After brain insult, matrixmetalloproteinases (MMPs) and vascular endothelial growth factors (VEGFs) are increased, causing disruption of tight junctions and BBB hyperpermeability. ETB-R antagonists attenuate the activation of astrocytes and production of MMPs and VEGFs. Dexamethasone (DEX) reduces the production of inflammatory factors and accelerates the stabilization of tight junctions. Thus, these agents are expected to be anti-vasogenic edema drugs. Brain insults induce dysfunctions of aquaporin 4 (AQP4), Na+–K+–Cl−–Co-Transporter 1 (KNCC1) and (sulfonylurea receptor 1) SUR1-regulated conselective cation channels (NCCa-ATP). These dysfunctions induce disruption of intra-extracellular Na+ and water balance, resulting in cell swelling. Thus, agents affecting AQP4, KNCC1 and SUR1-regulated NCCa-ATP would be beneficial for cytotoxic edema. Blue arrows: flow of water, green arrows: flow of Na+, orange spheres: albumin, green spheres: Na+, purple spheres: vascular permeability factors, brown triangle: inflammatory factors.
Figure 3 Involvement of key molecules and effects of candidate anti-edema drugs in brain edema. After brain insult, matrixmetalloproteinases (MMPs) and vascular endothelial growth factors (VEGFs) are increased, causing disruption of tight junctions and BBB hyperpermeability. ETB-R antagonists attenuate the activation of astrocytes and production of MMPs and VEGFs. Dexamethasone (DEX) reduces the production of inflammatory factors and accelerates the stabilization of tight junctions. Thus, these agents are expected to be anti-vasogenic edema drugs. Brain insults induce dysfunctions of aquaporin 4 (AQP4), Na+–K+–Cl−–Co-Transporter 1 (KNCC1) and (sulfonylurea receptor 1) SUR1-regulated conselective cation channels (NCCa-ATP). These dysfunctions induce disruption of intra-extracellular Na+ and water balance, resulting in cell swelling. Thus, agents affecting AQP4, KNCC1 and SUR1-regulated NCCa-ATP would be beneficial for cytotoxic edema. Blue arrows: flow of water, green arrows: flow of Na+, orange spheres: albumin, green spheres: Na+, purple spheres: vascular permeability factors, brown triangle: inflammatory factors.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Cited by

See all 348

Metadata

Authors
Michinaga, S., & Koyama, Y.
Affiliations
  • Osaka Ohtani University (JP)
  • Laboratory of Pharmacology, Faculty of Pharmacy, Osaka Ohtani University, Tonda-bayashi, Osaka 584-8540, Japan
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2015-04-30
Volume
16
Issue
5
Pages
9949-9975
ISSN
1422-0067 (ISSN-L)
OpenAlex
W2137653998
Cited by
339
References
202
Citations by year
2026: 25 · 2025: 25 · 2024: 46 · 2023: 41 · 2022: 40 · 2021: 52 · 2020: 38 · 2019: 21 · 2018: 14 · 2017: 23 · 2016: 12 · 2015: 1
FWCI
1.33
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
Japan Society for the Promotion of Science (15K07981)
Topics
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
  • Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion Transport and Channel Regulation
Keywords
cerebral edema, vasogenic edema, cytotoxic edema, blood-brain barrier disruption, intracranial pressure, stroke, head trauma, cell swelling
MeSH terms
Animals, Brain Edema, Glucocorticoids, Humans, Neuroprotective Agents, Vascular Endothelial Growth Factor A, Sodium Potassium Chloride Symporter Inhibitors, Matrix Metalloproteinase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.